John Svaren, PhD’s paper “Genome editing-enabled HTS assays expand drug target pathways for Charcot-Marie-Tooth disease,” examines how the use of genome editing places his research one step closer to a potential cure for Charcot-Marie-Tooth disease.
Month: September 2014
Down syndrome helps researchers understand Alzheimer’s disease
The link between a protein typically associated with Alzheimer’s disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin-Madison’s …
ALS community suddenly awash in awareness
If you hadn’t heard of ALS before this summer, you’re not alone. If you haven’t heard of it by now, you must be living under a rock. Not only did the ubiquitous ALS Ice Bucket Challenge raise about $100 million from late July to late August, it boosted awareness of ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.
Rep. Mark Pocan announces bill to support research funding during Waisman Center visit
U.S. Representative Mark Pocan (WI-02) visited the Waisman Center, University of Wisconsin-Madison on September 3 to discuss the Next Generation Research Act and federal funding to support early career researchers from the National Institutes of …